Published September 2, 2010 | Version v1
Patent Open

VITAMIN D AND VITAMIN D ANALOGS OR DERIVATIVES AS NEW ANTI-HYPERTENSIVE AGENTS

  • 1. University of Chicago

Contributors

Patent applicant:

Description

Methods and compositions to suppress renin expression and blood pressure in mammals are disclosed. Vitamin D and its analogues and derivatives, including Gemini compounds, are negative regulators of renin synthesis and blood pressure. Renin expression and plasma angiotensin II production were increased several fold in vitamin D receptor (VDR) null mice, leading to hypertension, cardiac hypertrophy and increased water intake. Vitamin D or its analogue-mediated regulation of renin expression and blood pressure is independent of calcium metabolism. Vitamin D analogues or derivatives are novel preventive or therapeutic anti-hypertension agents. Assays to identify novel vitamin D analogues or derivatives as anti-hypertensive agents are disclosed.

Files

US20100222307.pdf

Files (1.5 MB)

Name Size Download all
md5:b95b0567b96cad608b0960f9df3db7b9
1.5 MB Preview Download

Additional details

Identifiers

Patent application number
US 71513310 A
Patent number
US 2010/0222307 A1
Other
oai:uchicago.tind.io:9021

Dates

Patent filed
2010-03-01

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Medicine, Molecular Metabolism and Nutrition